| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fcaed31afee960c63f0d21e133fab13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_917d60cea79afd5e75452471d54b9beb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 |
| filingDate |
1980-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1983-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2944a7ad2e2d9bc092c152a1afe9b878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a838ef010f87db09608773b786c4fe7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f4feb7da076bc5d2967037b8c4f03f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23cc75b4acf9ec6f67aaf787301e5f7a |
| publicationDate |
1983-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4382925-A |
| titleOfInvention |
E-5-(2-Halogenovinyl)-2'-deoxycytidines |
| abstract |
The invention relates to E-5-(2-halogenovinyl)-2'-deoxycytidines, e.g. E-5-(bromovinyl)-2'-deoxycytidine and E-5-(2-iodovinyl)-2'-deoxycytidine. These substances are endowed with specific antiviral activities towards herpes simplex virus and with an extremely low toxicity which makes them useful in antiviral medicines and for treatment of virus diseases in man and animal. They may be synthesized by introduction of an E-5-(2-halogenovinyl) sidechain into 2'-deoxycytidine, or by condensation of a trialkylsilyl derivative of E-5-(2-halogenovinyl)-cytosine with a hydroxyl-protected reactive derivative of 2'-deoxy-D-erythro-pentofuranose. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003176392-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4544740-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4762823-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6670342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4782142-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7211570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4542210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-575918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4666892-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9001324-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003158149-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7638502-B2 |
| priorityDate |
1979-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |